ABSTRACT: Benzo[a]pyrene (BaP) is a human carcinogen that covalently binds to DNA after metabolic activation by cytochrome P450 (CYP) enzymes. Here we investigated the efficiencies of rat hepatic microsomes and rat recombinant CYP1A1 expressed with its reductase, NADPH:CYP oxidoreductase (POR), NADH:cytochrome b5 reductase, epoxide hydrolase and/or cytochrome b5 in Supersomes™ to metabolize this carcinogen. We also studied the effectiveness of coenzymes of two of the microsomal reductases, NADPH as a coenzyme of POR, and NADH as a coenzyme of NADH:cytochrome b5 reductase, to mediate BaP metabolism in these systems. Up to eight BaP metabolites and two DNA adducts were generated by the systems, both in the presence of NADPH and NADH. Among BaP metabolites, BaP-9,10-dihydrodiol, BaP-4,5-dihydrodiol, BaP-7,8-dihydrodiol, BaP-1,6-dione, BaP-3,6-dione, BaP-9-ol, BaP-3-ol, and a metabolite of unknown structure were formed by hepatic microsomes and rat CYP1A1. One of two DNA adducts formed by examined enzymatic systems (rat hepatic microsomes and rat CYP1A1) was characterized to be 10-(deoxyguanosin-N2-yl)-7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (dG-N2-BPDE), while another adduct has similar chromatographic properties on polyethylaneimine-cellulose thin layer chromatography to a guanine adduct derived from reaction with 9-hydroxy-BaP-4,5-oxide. In the presence of either of the reductase cofactors tested, NADPH or NADH, cytochrome b5 stimulated CYP1A1-mediated formation of both BaP-DNA adducts. The results demonstrate that NADH can act as a sole electron donor for both the first and the second reduction of CYP1A1 during its reaction cycle catalyzing oxidation of BaP, and suggest that the NADH:cytochrome b5 reductase as the NADH-dependent reductase might substitute POR in this enzymatic system.

Analytical and Environmental Sciences Division MRC PHE Centre for Environment and Health King's College London London SE1 9NH UK

Department of Biochemistry Faculty of Science Charles University Albertov 2030 128 40 Prague 2 Czech Republic

Division of Radiopharmaceutical Chemistry German Cancer Research Center Im Neuenheimer Feld 280 69120 Heidelberg Germany

Zobrazit více v PubMed

International Agency for Research on Cancer (IARC) Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr Eval Carcinog Risks Hum. 2010;92:1. PubMed PMC

Baird WM, Hooven LA, Mahadevan B. Environ Mol Mutagen. 2005;45:106. doi: 10.1002/em.20095. PubMed DOI

Wohak LE, Krais AM, Kucab JE, Stertmann J, Øvrebø S, Seidel A, Phillips DH, Arlt VM. Arch Toxicol. 2016;90:291. doi: 10.1007/s00204-014-1409-1. PubMed DOI PMC

Sims P, Grover PL, Swaisland A, Pal K, Hewer A. Nature. 1974;252:326. doi: 10.1038/252326a0. PubMed DOI

Wood AW, Levin W, Lu AY, Yagi H, Hernandez O, Jerina DM, Conney AH. J Biol Chem. 1976;251:4882. PubMed

Bauer E, Guo Z, Ueng YF, Bell LC, Zeldin D, Guengerich FP. Chem Res Toxicol. 1995;8:136. doi: 10.1021/tx00043a018. PubMed DOI

Arlt VM, Stiborová M, Henderson CJ, Thiemann M, Frei E, Aimová D, Singhs R, da Costa GG, Schmitz OJ, Farmer PB, Wolf CR, Philips DH. Carcinogenesis. 2008;29:656. doi: 10.1093/carcin/bgn002. PubMed DOI

Arlt VM, Poirier MC, Sykes SE, Kaarthik J, Moserova M, Stiborova M, Wolf R, Henderson CJ, Phillips DH. Toxicol Lett. 2012;213:160. doi: 10.1016/j.toxlet.2012.06.016. PubMed DOI PMC

Chun YJ, Shimada T, Guengerich FP. Arch Biochem Biophys. 1996;330:48. doi: 10.1006/abbi.1996.0224. PubMed DOI

Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR. Carcinogenesis. 1998;19:1847. doi: 10.1093/carcin/19.10.1847. PubMed DOI

Jiang H, Gelhaus SL, Mangal D, Harvey RG, Blair IA, Penning TM. Chem Res Toxicol. 2007;20:1331. doi: 10.1021/tx700107z. PubMed DOI PMC

Zhu S, Li L, Thornton C, Carvalho P, Avery BA, Willett KL. J Chromatogr B Anal Technol Biomed Life Sci. 2008;863:141. doi: 10.1016/j.jchromb.2008.01.018. PubMed DOI PMC

King HW, Thompson MH, Brookes P. Int J Cancer. 1976;18:339. doi: 10.1002/ijc.2910180311. PubMed DOI

Fang AH, Smith WA, Vouros P, Gupta RC. Biochem Biophys Res Commun. 2001;281:383. doi: 10.1006/bbrc.2000.4161. PubMed DOI

Stiborová M, Moserová M, Černá V, Indra R, Dračínský M, Šulc M, Henderson CJ, Wolf CR, Schmeiser HH, Phillips DH, Frei E, Arlt VM. Toxicology. 2014;318:1. doi: 10.1016/j.tox.2014.02.002. PubMed DOI

Guengerich FP. Chem Res Toxicol. 2008;21:70. doi: 10.1021/tx700079z. PubMed DOI

Porter TD. J Biochem Mol Toxicol. 2002;16:311. doi: 10.1002/jbt.10052. PubMed DOI

Schenkman JB, Jansson I. Pharmacol Ther. 2003;97:139. doi: 10.1016/S0163-7258(02)00327-3. PubMed DOI

McLaughin LA, Ronseaux S, Finn RD, Henderson CJ, Wolf CR. Mol Pharmacol. 2010;75:269. doi: 10.1124/mol.110.064246. PubMed DOI

Kotrbová V, Mrázová B, Moserová M, Martínek V, Hodek P, Hudeček J, Frei E, Stiborová M. Biochem Pharmacol. 2011;82:669. doi: 10.1016/j.bcp.2011.06.003. PubMed DOI

Stiborova M, Indra R, Moserova M, Cerna V, Rupertova M, Martínek V, Eckschlager T, Kizek R, Frei E. Chem Res Toxicol. 2012;25:1075. doi: 10.1021/tx3000335. PubMed DOI

Henderson CJ, McLaughlin LA, Wolf CR. Mol Pharmacol. 2013;83:1209. doi: 10.1124/mol.112.084616. PubMed DOI

Indra R, Moserova M, Sulc M, Frei E, Stiborova M. Neuro Endocrinol Lett. 2013;34(Suppl 2):55. PubMed

Steinberg P, Schlemper B, Molitor E, Platt KL, Seidel A, Oesch F. Environ Health Perspect. 1990;88:71. PubMed PMC

Marnett LJ, Bienkowski MJ. Biochem Biophys Res Commun. 1980;96:639. doi: 10.1016/0006-291X(80)91403-5. PubMed DOI

Marnett LJ. Environ Health Perspect. 1990;88:5. doi: 10.1289/ehp.90885. PubMed DOI PMC

Indra R, Moserova M, Kroftova N, Sulc M, Martinkova M, Adam V, Eckschlager T, Kizek R, Arlt VM, Stiborova M. Neuro Endocrinol Lett. 2014;35(Suppl 2):105. PubMed

Stiborova M, Dracinska H, Martinek V, Svaskova D, Hodek P, Milichovsky J, Hejdukova Z, Brotanek J, Schmeiser HH, Frei E. Chem Res Toxicol. 2013;26:290. doi: 10.1021/tx3004533. PubMed DOI

Krais AM, Speksnijder EN, Melis JP, Indra R, Moserova M, Godschalk RW, van Schooten FJ, Seidel A, Kopka K, Schmeiser HH, Stiborova M, Phillips DH, Luijten M, Arlt VM. Arch Toxicol. 2015 PubMed PMC

Sligar SG, Cinti DL, Gibson GG, Schenkman JB. Biochem Biophys Res Commun. 1979;90:925. doi: 10.1016/0006-291X(79)91916-8. PubMed DOI

Lewis DFV, Hlavica P. Biochim Biophys Acta. 2000;1460:354. PubMed

Meunier B, de Visser SP, Shaik S. Chem Rev. 2004;104:3947. doi: 10.1021/cr020443g. PubMed DOI

Berka K, Hendrychová T, Anzenbacher P, Otyepka M. J Phys Chem A. 2011;115:11248. doi: 10.1021/jp204488j. PubMed DOI PMC

Stiborová M, Martínek V, Rýdlová H, Hodek P, Frei E. Cancer Res. 2002;62:5678. PubMed

Kotrbová V, Aimová D, Brezinová A, Janouchová K, Poljaková J, Frei E, Stiborová M. Neuro Endocrinol Lett. 2006;27(Suppl 2):18. PubMed

Ross PH. Chromatogr B. 1996;684:107. doi: 10.1016/0378-4347(96)00018-7. PubMed DOI

Kotrbová V, Aimová D, Ingr M, Bořek-Dohalská L, Martínek V, Stiborová M. Protein Expr Purif. 2009;66:203. doi: 10.1016/j.pep.2009.03.011. PubMed DOI

Stiborová M, Bárta F, Levová K, Hodek P, Schmeiser HH, Arlt VM, Martínek V. Int J Mol Sci. 2015;16:27561. doi: 10.3390/ijms161126047. PubMed DOI PMC

Hodek P, Koblihová J, Kizek R, Frei E, Arlt VM, Stiborová M. Environ Toxicol Pharmacol. 2013;36:989. doi: 10.1016/j.etap.2013.09.004. PubMed DOI

Hodek P, Bořek-Dohalská L, Sopko B, Šulc M, Smrček S, Hudeček J, Janků J, Stiborová M. J Enzyme Inhib Med Chem. 2005;20:25. doi: 10.1080/14756360400024324. PubMed DOI

Chirulli V, Longo V, Marini S, Mazzaccaro A, Fiorio R, Gervasi PG. Life Sci. 2005;76:2535. doi: 10.1016/j.lfs.2004.09.042. PubMed DOI

Stiborová M, Bořek-Dohalská L, Aimová D, Kotrbová V, Kukačková K, Janouchová K, Rupertová M, Ryšlavá H, Hudeček J, Frei E. Gen Physiol Biophys. 2006;25:245. PubMed

Stiborová M, Breuer A, Aimová D, Stiborová-Rupertová M, Wiessler M, Frei E. Int J Cancer. 2003;107:885. doi: 10.1002/ijc.11511. PubMed DOI

Wiechelman KJ, Braun RD, Fitzpatrick JD. Anal Biochem. 1988;75:231. doi: 10.1016/0003-2697(88)90383-1. PubMed DOI

Moserová M, Kotrbová V, Aimová D, Šulc M, Frei E, Stiborová M. Interdisc Toxicol. 2009;2:239. doi: 10.2478/v10102-009-0024-0. PubMed DOI PMC

Schmeiser HH, Stiborova M, Arlt VM. Methods Mol Biol. 2013;1044:389. doi: 10.1007/978-1-62703-529-3_21. PubMed DOI

Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats

Cytochrome b 5 impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b 5 /P450 reductase null (HBRN) mice

Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[a]pyrene in prokaryotic and eukaryotic expression systems

Cytochrome b5 plays a dual role in the reaction cycle of cytochrome P450 3A4 during oxidation of the anticancer drug ellipticine

NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene